Checking LXRX unusual options activity helps you spot when traders are making outsized bets on Lexicon Pharmaceuticals Inc before the broader market catches on. Lexicon Pharmaceuticals Inc's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor LXRX unusual options activity today and surface the prints that deserve a second look.
Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching LXRX unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking LXRX unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and LXRX unusual options flow data becomes especially valuable around earnings, product launches, and macro events.
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; and LX9211, which is in Phase II clinical development for the treatment of neuropathic pain. The company has strategic collaboration and license agreements with Bristol-Myers Squibb Company, and Genentech, Inc. Lexicon Pharmaceuticals, Inc. was incorporated in 1995 and is headquartered in The Woodlands, Texas.
Catalysts rarely arrive without a footprint, and LXRX unusual options activity is often where that footprint shows up first. Our scanner tracks Lexicon Pharmaceuticals Inc's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at LXRX unusual options volume on the call side or chasing put sweeps, Lexicon Pharmaceuticals Inc's unusual options flow today is one click away, so put it on your radar before the headlines hit.
